Certified Pharmaceutical GMP Professional Practice

The implementation of CAPA aims to do what?

1. Enhance financial outcomes

2. Address risks causing hazards and prevent recurrence

3. Increase employee engagement

4. Improve market competitiveness

The correct answer is: Address risks causing hazards and prevent recurrence

The implementation of CAPA, which stands for Corrective and Preventive Action, is fundamentally about addressing the root causes of issues that have arisen within a process or system. The primary aim is to identify and eliminate risks that could lead to nonconformities or hazards in the manufacturing and quality processes. By effectively investigating and addressing these risks, CAPA helps to prevent the recurrence of issues that could compromise product quality or patient safety. In the context of pharmaceutical manufacturing, adherence to Good Manufacturing Practices (GMP) is crucial, and CAPA plays a vital role in maintaining compliance. The process encourages organizations to not only react to issues that have already occurred but also to take proactive steps to mitigate potential risks. This continuous improvement cycle is essential for ensuring that processes remain safe, efficient, and effective. While the other options may represent valuable organizational objectives, they do not capture the core purpose of CAPA as clearly as addressing risks and preventing recurrence does. Financial outcomes, employee engagement, and market competitiveness may indirectly benefit from a strong CAPA program, but they are not the primary focus or intended outcomes of CAPA implementation.